A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.
Clinical trial NCT00002199 · COMPLETED
Trial details
- NCT number
- NCT00002199
- Sponsor
- Glaxo Wellcome
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.